Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Chemotherapy

New consent forms for cancer treatments published

Cancer patients are being given a new consent form to better explain the drugs they will be given before starting treatment.

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

Watch our Google Hangout about testing new treatments in patients (Part 2 of 2)

We explore how clinical trials are run, and hear from a patient about what it's like taking part in a cancer clinical trial.

Cancer Research UK launches new trial to test drug against resistant bladder cancer

A clinical trial to test a drug which may stop bladder cancers becoming resistant to chemotherapy is being launched by Cancer Research UK.

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

Balls of cells with their own ‘passport’ to help speed up cancer drug testing

We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.

High-tech scans spare lymphoma patients intensive chemo

Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

Test could spare breast cancer patients unnecessary chemotherapy

A gene test may improve the way doctors treating women with early-stage breast cancer identify those who can safely avoid post-surgery chemotherapy.

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

Pages